The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
To be a shareholder in EssilorLuxottica, you need to believe the group can successfully capitalize on the rapid adoption of AI-driven eyewear and vision care platforms, while balancing profitability pressures from technology investments and ongoing margin risks. The recent record third-quarter revenue, fuelled by robust demand for AI-powered Meta smart glasses, supports the key short-term catalyst of wearable expansion but does not materially shift the largest risk, possible margin dilution if these new products do not sustain longer-term relevance and market pricing power.
Among the recent developments, the September unveiling of next-generation AI glasses with Meta directly ties into the current sales surge, reinforcing investor focus on the company's ability to translate leading-edge innovation into tangible revenue growth. This momentum gives EssilorLuxottica clear visibility as a frontrunner in smart eyewear, which remains a core catalyst highlighted by strong recent quarters and ongoing product launches.
Yet, in contrast to the recent excitement, investors should consider how elevated R&D and marketing costs could pressure margins if wearable sales...
Read the full narrative on EssilorLuxottica Société anonyme (it's free!)
EssilorLuxottica Société anonyme’s outlook anticipates €32.6 billion in revenue and €3.7 billion in earnings by 2028. This is based on an annual revenue growth rate of 6.1%, and reflects a €1.3 billion increase in earnings from the current level of €2.4 billion.
Uncover how EssilorLuxottica Société anonyme's forecasts yield a €303.95 fair value, a 3% downside to its current price.
Simply Wall St Community members have shared eight fair value estimates for EssilorLuxottica, with individual targets ranging widely from €200.22 to €400.08 per share. While many are focused on innovation as a key growth catalyst, this diversity of opinion shows how differently investors weigh the potential and risks of new product adoption.
Explore 8 other fair value estimates on EssilorLuxottica Société anonyme - why the stock might be worth 36% less than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com